Michael Hart

Michael Hart is an experienced professional in the business and investment world. He currently serves as an Investor and Advisor at Kluster. Some key points about Michael Hart's background and experience include:

• He has expertise in global accounts and focuses on simplifying data.

• Michael has a broad background in executive leadership roles. He was previously the President and CEO of Allos Therapeutics, Inc. from 2001 to 2006.1

• Prior to that, he served as Chief Financial Officer and Senior Vice President of Operations at Allos Therapeutics from 1999 to 2001.1

• He has significant experience in the biotechnology and pharmaceutical industries, having also worked as Vice President and CFO of NeXstar Pharmaceuticals from 1990 to 1999.1

• Michael holds an MBA degree and has over 20 years of executive experience.1

• He has been involved in major business transactions, including leading a $95 million merger between Vestar and NeXagen to form NeXstar Pharmaceuticals, and the subsequent $550 million acquisition of NeXstar by Gilead Sciences.1

• After his full-time industry roles, Michael formed a business consulting practice focused on executive advisory services and serving on boards of directors.1

• He co-founded ClearMind Advisors, an executive leadership and coaching company, in 2016.1

Michael Hart's diverse experience in executive leadership, finance, and advisory roles across various industries, particularly in biotechnology, has equipped him with valuable insights that he now applies in his investor and advisor capacity at Kluster.